Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Unexplained recurrent pregnant loss (URPL) is associated with immune imbalance at the maternal-fetal interface. Decidual immune cells regulate the response of the maternal immune system to the fetus. However, the effect of decidual stromal cells (DSCs) and trophoblast cells on cytokine secretion by decidual NK cells remains unclear. In this study, we investigated the influence of JEG-3 cells and DSCs on the secretion of cytokines in dNK cells. Furthermore, we investigated whether or not cytokine secretion was regulated by the mitogen-activated protein kinase (MAPK) signaling pathway at the maternal-fetal interface. Our study showed that the secretions of both IFN-γ and TNF-α in dNK cells in URPL were significantly higher than those in normal pregnancy. In the coculture of JEG-3, DSCs, and dNK cells, IL-10 and IL-4 production increased in dNK cells during normal pregnancy; whereas IFN-γ and TNF-α production increased but IL-10 and IL-4 levels decreased during URPL. Furthermore, pretreatment with P38/MAPK inhibition significantly inhibited the secretion of NK1- and NK2-type cytokines in the coculture of the three types of cells. Our study elucidated the influence of trophoblasts and DSCs on the expression of cytokines in dNK cells in patients with URPL and uncovered a complicated crosstalk through the MAPK signal at the maternal-fetal interface.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/09513590.2025.2497857 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dysregulation of decidual NK cell proliferation by impaired decidual cells: a potential contributor to excessive trophoblast invasion in placenta accreta spectrum.
Front Cell Dev Biol
July 2025
Graduate Institute of Pharmacology, National Taiwan University College of Medicine, Taipei, Taiwan, United States.
Aberrant interactions among decidual stromal cells, decidual natural killer (dNK) cells, and trophoblasts are implicated in placenta accreta spectrum (PAS) pathogenesis, though the underlying mechanisms remain unclear. This study investigates the relationship between defective decidualization of endometrial stromal cells and dysregulated dNK cell proliferation, which may contribute to excessive trophoblast invasion and the development of PAS. We established an system that mimics the decidual microenvironment to investigate these interactions.
View Article and Find Full Text PDFGranulysin-high decidual NK cells in macaques and humans share signatures of immune defense.
Cell Rep
July 2025
Divisions of Neonatology and Developmental Biology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address:
Decidual natural killer cells (dNKs) are key immune effector cells at the maternal-fetal interface. dNKs utilize the antimicrobial peptide granulysin (GNLY) to kill bacteria without killing infected trophoblasts. Since rodents lack the GNLY gene, the in vivo biology of GNLY expression by dNKs and their role during intra-uterine infection (IUI) is not well understood.
View Article and Find Full Text PDFDecoding the Maternal-Fetal Dialogue: NK Cell Education in Reproductive Outcomes†.
Biol Reprod
June 2025
Center of Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
Natural killer (NK) cell education, a dynamic and finely tuned process, is essential for calibrating decidual NK (dNK) cell responsiveness at the maternal-fetal interface. This education process, governed by distinct receptor-ligand interactions, refines dNK cell function to maintain immune tolerance while preserving responsiveness to pathological threats. Killer-cell immunoglobulin-like receptors (KIRs) interacting with human leukocyte antigen (HLA)-C dictate a balance between activation and inhibition, shaping dNK cell adaptability to maternal-fetal genetic variation.
View Article and Find Full Text PDFTRAF3 as a potential diagnostic biomarker for recurrent pregnancy loss: insights from single-cell transcriptomics and machine learning.
BMC Pregnancy Childbirth
May 2025
Reproductive Center, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
Background: Recurrent pregnancy loss (RPL), characterized by multiple miscarriages, remains a condition with unclear etiology, posing significant challenges for affected women and couples. This study aims to explore the underlying mechanisms of RPL, focusing on the role of decidual Natural Killer (dNK) cells and the TNF receptor-associated factor 3 (TRAF3) gene as a potential diagnostic marker and therapeutic target.
Methods: We used single-cell transcriptomic analysis and machine learning techniques to analyze decidual tissues from RPL patients and normal pregnancy(NP).
Cancer therapy via neoepitope-specific monoclonal antibody cocktails.
Cancer Immunol Immunother
May 2025
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, 14 Engineering Drive, Hanover, NH, 03755, USA.
Cellular heterogeneity presents a significant challenge to cancer treatment. Antibody therapies targeting individual tumor-associated antigens can be extremely effective but are not suited for all patients and often fail against tumors with heterogeneous expression as tumor cells with low or no antigen expression escape targeting and develop resistance. Simultaneously targeting multiple tumor-specific proteins with multiple antibodies has the potential to overcome this barrier and improve efficacy, but relatively few widely expressed cancer-specific antigens are known.
View Article and Find Full Text PDF